Know Cancer

or
forgot password

99mTechnetium-MIBI SPECT-CT for Pre-operative Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma; A Pilot Study


N/A
18 Years
N/A
Open (Enrolling)
Both
Papillary Thyroid Cancer

Thank you

Trial Information

99mTechnetium-MIBI SPECT-CT for Pre-operative Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma; A Pilot Study


Inclusion Criteria:



- papillary thyroid cancer

Exclusion Criteria:

- pregnancy

- Bleeding abnormality

- Prior history of head and neck cancer

- can not perform 99mTechnetium-MIBI SPECT-CT

- can not perform 131I remnant Ablation

- Prior any head and neck surgery within 3 months

- Prior deep neck infection within 3 months

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )

Outcome Time Frame:

18 months

Safety Issue:

No

Principal Investigator

Napadon Tangjaturonrasme, Otolaryngologist

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Otolaryngology , Faculty of Medicine , Chulalongkorn University

Authority:

Thailand: Ethical Committee

Study ID:

NapadonChula_01

NCT ID:

NCT00984191

Start Date:

March 2010

Completion Date:

November 2011

Related Keywords:

  • Papillary Thyroid Cancer
  • Papillary thyroid cancer
  • 99mTechnetium MIBI SPECT CT
  • preoperative
  • cervical lymphadenopathy
  • cervical metastasis
  • Carcinoma
  • Thyroid Neoplasms
  • Carcinoma, Papillary
  • Thyroid Diseases

Name

Location